The effect of oral 3,3′-diindolylmethane supplementation on the 2:16α-OHE ratio in BRCA1 mutation carriers

This publication has 44 references indexed in Scilit:

• Multi-nutrient supplement improves hormone ratio associated with cancer risk
  Journal of Translational Medicine, 2013
• Phytochemicals and Cancer Risk
  Nutrition in Clinical Practice, 2012
• 3,3′-Diindolylmethane Modulates Estrogen Metabolism in Patients with Thyroid Proliferative Disease: A Pilot Study
  Thyroid®, 2011
• Low Concentrations of Diindolylmethane, a Metabolite of Indole-3-Carbinol, Protect against Oxidative Stress in a BRCA1-Dependent Manner
  Cancer Research, 2009
• Urinary estrogen metabolites in women at high risk for breast cancer
  Carcinogenesis, 2009
• Aromatase expression is increased in BRCA1mutation carriers
  BMC Cancer, 2009
• Single-Dose Pharmacokinetics and Tolerability of Absorption-Enhanced 3,3′-Diindolylmethane in Healthy Subjects
  Cancer Epidemiology, Biomarkers & Prevention, 2008
• Circulating 2-Hydroxy- and 16α-Hydroxy Estrone Levels and Risk of Breast Cancer among Postmenopausal Women
  Cancer Epidemiology, Biomarkers & Prevention, 2008
• Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
  The American Journal of Human Genetics, 2003
• Diet and urinary estrogen profile in premenopausal omnivorous and vegetarian women and in premenopausal women with breast cancer
  Journal of Steroid Biochemistry, 1989